Neinor Homes SLU (HOME)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 16.90 |
|---|---|
| 52-week range | 14.38 – 21.00 |
| Return, 1 month / 3 months | +6.9% / +5.4% |
| Return, 1 year / 3 years | +11.0% / +139.5% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 22.9% |
| Worst drawdown (1 year) | -21.7% |
| Average daily value traded | 4.23M EUR |
| Dividend yield | 10.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Neinor Homes is a Spanish residential property developer based in Madrid. The company builds new homes for sale, focusing on apartments and housing developments in cities and regions across Spain. Its customers are mainly private homebuyers, and it also works with land owners and partners on residential projects. Neinor Homes takes part in the full process of developing homes, from acquiring land and planning through construction to handing over finished properties to buyers.
On this site Neinor Homes SLU appears as a stock on the Madrid Exchange (Spain), code HOME, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Neinor Homes SLU (HOME) trades on the Madrid Exchange in Spain. It last closed at EUR 16.90 on 22 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 64 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.0% and over the last three months it rose 5.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.6% | ||
| From 52-week high | -18.6% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.4% | ||
| 6-month return | 4.4% | ||
| 12-month return, skipping the last month | 3.9% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.7% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 4.23M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.1% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | +6.9% |
| 3 months | +5.4% |
| 6 months | +4.4% |
| 1 year | +11.0% |
| 3 years | +139.5% |
| 5 years | +144.3% |
Signals
| 50-day / 200-day average | 15.94 / 16.31 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.7794 |
| 10 Feb 2026 | EUR 0.9327 |
| 12 May 2025 | EUR 0.4100 |
| 12 Mar 2025 | EUR 0.8300 |
| 22 Jan 2025 | EUR 0.8300 |
| 11 Oct 2024 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.